US Stock Market Move | Most of the Chinese pharmaceutical stocks rose, BEIGENE (ONC.US) by over 9%
Most Chinese pharmaceutical stocks are up, as of press time, BeiGene's shares surged more than 9%.
On Tuesday, most of the Chinese pharmaceutical stocks rose. As of press time, BeiGene (ONC.US) rose by over 9%, HutchMed (HCM.US) rose by over 4%; and Zai Lab (ZLAB.US) dipped slightly by 0.08%. In terms of news, BeiGene CEO John Oyler mentioned that, according to US Generally Accepted Accounting Principles, the company is expected to achieve a positive operating profit for the full year of 2025 (meaning that operating income will exceed the sum of operating costs, sales expenses, management expenses, and research and development expenses).
Related Articles
Guosheng Securities: It is almost certain that the Federal Reserve will continue to cut interest rates in October and December. It is expected that there will be three more rate cuts in 2026.
CMSC: Hong Kong stocks return to growth style after adjustment, focusing on internet and insurance.
The Chinese Olympic Committee and LI NING brand jointly release the award-winning equipment for the Chinese sports delegation at the 2026 Milan Winter Olympics.
Guosheng Securities: It is almost certain that the Federal Reserve will continue to cut interest rates in October and December. It is expected that there will be three more rate cuts in 2026.
CMSC: Hong Kong stocks return to growth style after adjustment, focusing on internet and insurance.
The Chinese Olympic Committee and LI NING brand jointly release the award-winning equipment for the Chinese sports delegation at the 2026 Milan Winter Olympics.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
